BLUEBIRD STRATEGIES

Lobbying for MYOTONIC · Patient advocacy organization.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · posted Nov 9, 2025

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Funding for myotonic dystrophy research as part of the FY26 Congressionally Directed Medical Research Program

Budget/Appropriations

Myotonic dystrophy biomedical research funding

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.